Euphrates Vascular develops medical devices that treat vascular occlusions related to vascular disease.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: St Louis
State: Missouri
Zip:
Country: United States
Euphrates Vascular develops medical devices that treat vascular occlusions related to vascular disease. Euphrates Vascular&s;s Magnetically-Enhanced Diffusion system uses patented magnet-based technology to transport iron-oxide MED MicroBeads and clot-busting drugs at a much faster rate than otherwise possible, enabling doctors to improve care for stroke and other diseases. Euphrates Vascular was created through the merger of Pulse Therapeutics and ICHOR Vascular.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2021 | Venture Round | $6M |
---|
Announced Date | Name | Price |
---|---|---|
1/2019 | Pulse Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|